Core Viewpoint - Medike (688079.SH) announced that Fengsheng Jiamei plans to reduce its shareholding by up to 12.2021 million shares, representing no more than 3% of the total share capital, starting from September 9, 2025, within a three-month period [1] Summary by Category - Share Reduction Details - Fengsheng Jiamei will reduce its holdings by a maximum of 12.2021 million shares, which is up to 3% of the total share capital [1] - The reduction will occur through two methods: a maximum of 4.0674 million shares (up to 1% of total share capital) will be sold via centralized bidding, and a maximum of 8.1348 million shares (up to 2% of total share capital) will be sold through block trading [1] - The selling price will be determined based on market prices [1]
美迪凯(688079.SH):丰盛佳美拟减持不超3%股份